# Opioid Induced Gait Variability

> **NCT03121547** · PHASE1,PHASE2 · COMPLETED · sponsor: **Frederiksberg University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Opioid Induced Motor Disturbances

## Interventions

- **DRUG:** Tapentadol 50 mg Oral Tablet
- **DRUG:** Tramadol Hydrochloride 100 mg Extended Release Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03121547
- **Lead sponsor:** Frederiksberg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-19
- **Primary completion:** 2016-01-29
- **Final completion:** 2016-01-29
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03121547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03121547, "Opioid Induced Gait Variability". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03121547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*